Founded in 2007, Patsnap is the global leader in AI-powered IP and R&D intelligence, empowering experts in these fields by providing insightful answers that enable faster, confident decision-making. Our domain-specific large language model (LLM), trained on an extensive collection of proprietary antibody-antigen, nucleotide sequence and patent data, along with Hiro, our AI assistant, delivers actionable insights that enhance productivity by 75% and reduce R&D waste by 25%, accelerating your R&D and commercialization cycle. Bio by Patsnap assists life science organizations in validating novel biologic molecules, mitigating risk, and fostering innovation with confidence, curated from millions of patent and non-patent sources. With over 2.9M+ sequences, Bio by Patsnap is the world’s largest sequence-patent database, offering advanced features such as cutting-edge antibody-antigen pairing, unique chemical modification data, and comprehensive sequence analysis, enabling users to confidently accelerate biologics freedom to operate (FTO) search. It provides extensive coverage for patent FTO and novel checks within the rapidly evolving landscapes of antibody-drug conjugates (ADCs), RNA therapies, and nucleotide-based therapeutics. Key Features: - Bio is the industry-leading SaaS solution tailored for IP and R&D teams within the life science industry, offering key functionalities such as: - AI-powered sequence search and analysis tool - All-in-one search for sequences, structures, patents, and keywords - Efficient indexing of biologics, targets and sequences through AI-powered and manual annotation - State-of-the-art scenario-based sequence retrieval algorithms - Patent sequence highlighting for FTO analysis - Automated analysis reports and visualization charts - Collaborative shared workspace and data export features And more! Bio by Patsnap enables IP and R&D leaders to expedite biosequence FTO processes with AI, fast-tracking innovations to commercialization at speed.